193 related articles for article (PubMed ID: 18954907)
1. The antidepressant debate and the balanced placebo trial design: an ethical analysis.
Waring DR
Int J Law Psychiatry; 2008 Dec; 31(6):453-62. PubMed ID: 18954907
[TBL] [Abstract][Full Text] [Related]
2. Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants.
Dowrick CF; Hughes JG; Hiscock JJ; Wigglesworth M; Walley TJ
BMC Health Serv Res; 2007 Apr; 7():64. PubMed ID: 17470280
[TBL] [Abstract][Full Text] [Related]
3. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
4. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
Papakostas GI; Fava M
Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
[TBL] [Abstract][Full Text] [Related]
5. Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression.
Rihmer Z; Dome P; Baldwin DS; Gonda X
Eur Neuropsychopharmacol; 2012 Nov; 22(11):782-6. PubMed ID: 22497852
[TBL] [Abstract][Full Text] [Related]
6. Placebo, prozac and PLoS: significant lessons for psychopharmacology.
Horder J; Matthews P; Waldmann R
J Psychopharmacol; 2011 Oct; 25(10):1277-88. PubMed ID: 20571143
[TBL] [Abstract][Full Text] [Related]
7. Impact of study design on the results of continuation studies of antidepressants.
Zimmerman M; Posternak MA; Ruggero CJ
J Clin Psychopharmacol; 2007 Apr; 27(2):177-81. PubMed ID: 17414242
[TBL] [Abstract][Full Text] [Related]
8. Study designs and outcomes in antidepressant clinical trials.
Khan A; Schwartz K
Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
[TBL] [Abstract][Full Text] [Related]
9. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
D'Agostino RB; Massaro JM; Sullivan LM
Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
[TBL] [Abstract][Full Text] [Related]
10. Ethical framework for the use of sham procedures in clinical trials.
Horng S; Miller FG
Crit Care Med; 2003 Mar; 31(3 Suppl):S126-30. PubMed ID: 12626957
[TBL] [Abstract][Full Text] [Related]
11. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
Deisenhammer EA; Hinterhuber H
Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
[TBL] [Abstract][Full Text] [Related]
12. Do antidepressants work? A commentary on "Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration" by Kirsch et al.
McAllister-Williams RH
Evid Based Ment Health; 2008 Aug; 11(3):66-8. PubMed ID: 18669671
[No Abstract] [Full Text] [Related]
13. Drug-placebo difference: in antidepressant drug trials could be 50% greater than previously believed.
Rihmer Z
Neuropsychopharmacol Hung; 2007 Mar; 9(1):35-7. PubMed ID: 17879563
[TBL] [Abstract][Full Text] [Related]
14. Rationale for a non-inferiority clinical trial design focused on subpopulations.
Kulkarni PM; Meadows ES; Ahuja S; Muram D; Plouffe L
Curr Med Res Opin; 2004 Oct; 20(10):1641-7. PubMed ID: 15462697
[TBL] [Abstract][Full Text] [Related]
15. [Critical of the additive model of the randomized controlled trial].
Boussageon R; Gueyffier F; Bejan-Angoulvant T; Felden-Dominiak G
Therapie; 2008; 63(1):29-35. PubMed ID: 18387273
[TBL] [Abstract][Full Text] [Related]
16. Ethical issues of placebo-controlled studies in depression and a randomized withdrawal trial in Japan: case study in the ethics of mental health research.
Tashiro S; Yamada MM; Matsui K
J Nerv Ment Dis; 2012 Mar; 200(3):255-9. PubMed ID: 22373766
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue.
Fountoulakis KN; Möller HJ
J Psychopharmacol; 2012 May; 26(5):744-50. PubMed ID: 21926425
[TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled studies in depression: necessary, ethical and feasible.
Baldwin D; Broich K; Fritze J; Kasper S; Westenberg H; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):22-8. PubMed ID: 12664309
[TBL] [Abstract][Full Text] [Related]
19. A case study comparing a randomized withdrawal trial and a double-blind long-term trial for assessing the long-term efficacy of an antidepressant.
Mallinckrodt C; Chuang-Stein C; McSorley P; Schwartz J; Archibald DG; Perahia DG; Detke MJ; Alphs L
Pharm Stat; 2007; 6(1):9-22. PubMed ID: 17238129
[TBL] [Abstract][Full Text] [Related]
20. Placebo-free designs for evaluating new mental health treatments: the use of adaptive treatment strategies.
Dawson R; Lavori PW
Stat Med; 2004 Nov; 23(21):3249-62. PubMed ID: 15490427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
